Intensified process formats promise improved cost efficiency in biotherapeutics production by lowering cost of goods and increasing plant flexibility. CHO clones from traditional cell line development differ in responsiveness to process intensification and sometimes fail altogether. Therefore, tailored and time-efficient approaches are key to selecting suitable clones and developing associated ...
By Sartorius AG
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you